225 related articles for article (PubMed ID: 29716922)
1. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ
Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922
[No Abstract] [Full Text] [Related]
2. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression.
Chen JL; Li J; Kiriluk KJ; Rosen AM; Paner GP; Antic T; Lussier YA; Vander Griend DJ
Clin Cancer Res; 2012 Aug; 18(16):4291-302. PubMed ID: 22723371
[TBL] [Abstract][Full Text] [Related]
4. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.
VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ
Elife; 2020 Jun; 9():. PubMed ID: 32553107
[TBL] [Abstract][Full Text] [Related]
5. Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation.
Alshalalfa M; Abou-Ouf H; Davicioni E; Karnes RJ; Alhajj R; Bismar TA
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2223-2231. PubMed ID: 33864110
[TBL] [Abstract][Full Text] [Related]
6. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG
Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068
[TBL] [Abstract][Full Text] [Related]
7. Control of mouse limb initiation and antero-posterior patterning by Meis transcription factors.
Delgado I; Giovinazzo G; Temiño S; Gauthier Y; Balsalobre A; Drouin J; Torres M
Nat Commun; 2021 May; 12(1):3086. PubMed ID: 34035267
[TBL] [Abstract][Full Text] [Related]
8. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy.
Weiner AB; Faisal FA; Davicioni E; Karnes RJ; Griend DJV; Lotan TL; Schaeffer EM
Eur Urol Oncol; 2021 Dec; 4(6):955-962. PubMed ID: 32540218
[TBL] [Abstract][Full Text] [Related]
9. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis.
Meriç N; Albayrak E; Gülbaş Z; Kocabaş F
Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of MEIS2 in prostate cancer recurrence.
Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD
Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805
[TBL] [Abstract][Full Text] [Related]
11. Newly developed MEIS inhibitor selectively blocks MEIS
Girgin B; Kocabaş F
Gene; 2023 Jun; 871():147425. PubMed ID: 37044182
[TBL] [Abstract][Full Text] [Related]
12. The role of the MEIS homeobox genes in neuroblastoma.
Geerts D; Schilderink N; Jorritsma G; Versteeg R
Cancer Lett; 2003 Jul; 197(1-2):87-92. PubMed ID: 12880965
[TBL] [Abstract][Full Text] [Related]
13. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
14. MEIS C termini harbor transcriptional activation domains that respond to cell signaling.
Huang H; Rastegar M; Bodner C; Goh SL; Rambaldi I; Featherstone M
J Biol Chem; 2005 Mar; 280(11):10119-27. PubMed ID: 15654074
[TBL] [Abstract][Full Text] [Related]
15. Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2.
Han D; Li X; Cheng Y
Chem Res Toxicol; 2023 Mar; 36(3):360-368. PubMed ID: 36763086
[TBL] [Abstract][Full Text] [Related]
16. MEIS and PBX homeobox proteins in ovarian cancer.
Crijns AP; de Graeff P; Geerts D; Ten Hoor KA; Hollema H; van der Sluis T; Hofstra RM; de Bock GH; de Jong S; van der Zee AG; de Vries EG
Eur J Cancer; 2007 Nov; 43(17):2495-505. PubMed ID: 17949970
[TBL] [Abstract][Full Text] [Related]
17. MEIS1 functions as a potential AR negative regulator.
Cui L; Li M; Feng F; Yang Y; Hang X; Cui J; Gao J
Exp Cell Res; 2014 Oct; 328(1):58-68. PubMed ID: 25158280
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
19. The Gene Regulatory Network of Lens Induction Is Wired through Meis-Dependent Shadow Enhancers of Pax6.
Antosova B; Smolikova J; Klimova L; Lachova J; Bendova M; Kozmikova I; Machon O; Kozmik Z
PLoS Genet; 2016 Dec; 12(12):e1006441. PubMed ID: 27918583
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell Carcinoma.
Moghbeli M; Rad A; Farshchian M; Taghehchian N; Gholamin M; Abbaszadegan MR
J Gastrointest Cancer; 2016 Sep; 47(3):273-7. PubMed ID: 27142513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
